Bìol. Tvarin, 2017, Volume 19, Issue 1, pp. 8892


V. N. Plysiuk1,2, M. I. Tsvilikhovski1

This email address is being protected from spambots. You need JavaScript enabled to view it.; This email address is being protected from spambots. You need JavaScript enabled to view it.

1National University of Life and Environmental Sciences of Ukraine,
15 Heroiv Oborony str., Kyiv, 03041, Ukraine

2Network of veterinary clinics VC «Alden-Vet»,
10 А V. Lobanovsky pr., Kyiv 03037 Ukraine

This article presents a modern approach to the opportunities of diagnosing fibrosis of the myocardium in domestic cats and other forms of hypertrophic cardiomyopathy. The causes of fibrosis in the myocardium can be considered a partial completion of the process of inflammation, because disruption of proliferation, which is the final stage of inflammation, and leads to excessive accumulation of collagen and fibrosis of the myocardium. Prior to the development of chronic inflammation and fibrosis can result as insufficient number of macrophages in inflammation foci, and their numerous clusters.

By the studies of heart pathologies in recent years, more and more scientists believe that fibrotic changes in the myocardium are the primary factor in the development of hypertrophic cardiomyopathy.

The aim was to study the possibilities of diagnosing fibrotic effects in the myocardium of domestic cat with cardiomyopathies. In the performance of methods ultrasound of the heart and myocardial histology cats with confirmed diagnosis of cardiomyopathy were applied.

The data obtained from the studies will likely confirm the presence of fibrosis in myocardium domestic cats for cardiomyopathy. Also, analysis of information from the histological studies of myocardial dead cats makes it possible to ensure that fibrotic changes in heart muscle domestic cats may result from chronic myocarditis in those animals. The result of the work done is logical to believe that cardiomyopathies in domestic cats are secondary and acquired from the suffering of the underlying disease.

Nowadays, ultrasound of the heart of domestic cats can be considered the only available non-invasive method for diagnosing and evaluating the presence and development of fibrosis in the myocardium.


1. Ado A. D. Pathological physiology. M., Triad-X, 2000, 574 p. (in Russian)
2. Amosova K. M. Cardiomyopathy. Kyiv, Book plus, 1999, 213 p. (in Ukrainian)
3. Drapkina O. M., Drapkina Yu. S. Fibrosis and renin-angiotensin-aldosterone system activity. Reality and future prospects. Arterial hypertension, 2012, vol. 18, no. 5, pp. 449–455. (in Russian)
4. Drapkina O. M., Cherkunova E. V. Evaluation of atrial contractile function disorders and fibrosis as predictors of chronic heart failure. Rational Pharmacotherapy in Cardiology, 2014, vol. 10, no. 2, pp. 231–237. (in Russian) https://doi.org/10.20996/1819-6446-2014-10-2-231-237
5. Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol. Endocrinol., 2009, vol. 23, no. 1, pp. 11–24.
6. Lebedeva A. I., Muslimov S. A., Musina L. A. Experimental modeling of the chronic inflammation process and fibrosis. Biomedicine, 2013, no. 4, pp. 114–123. (in Russian) https://doi.org/10.1210/me.2008-0183
7. Litvitsky P. F. Inflammation. Current Pediatrics, 2006, vol. 5, no. 3, pp. 46–51. (in Russian)
8. Savchenko M. I., Kovalev Yu. R., Kuchinskiy A. P. Hypertrophic cardiomyopathy: fibrosis or hypertrophy. Arterial hypertension, 2013, vol. 19, no. 2, pp. 148–155. (in Russian)
9. Storozchakov G. I. Cardiomyopathies: Evolutions of Views of the Problem. Medical business, 2009, no 1, pp. 3–12. (in Russian)
10. Tsyplenkova V. G., Illarionova N. G. The study of mechanisms of death of cardiomyocytes during noncoronary heart disease. International Journal of Applied and Basic Research, 2010, no. 10, pp. 91–92. (in Russian)

Download full text in PDF format




WorldCat Logo